跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,352 条关于
“Mixed Hyperlipidemia”
全部
5,352
临床试验
4,446
药物
56
机构
5
资讯
845
去年
Plozasiran Shows Promise in Reducing Cholesterol and Triglycerides in Mixed Hyperlipidemia Patients
18天前
ANGPTL3 Inhibitors Market Poised to Reach $3.48 Billion by 2035 as Pipeline Diversifies Beyond Monoclonal Antibodies
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
去年
Plozasiran Shows Promise in Reducing Triglycerides in Phase 3 and Extension Studies
11个月前
CSPC Pharmaceutical's SYH2070 siRNA Injection Receives Dual FDA and NMPA Approval for Lipid Disorder Trials
去年
Arrowhead Pharmaceuticals Files Patent Lawsuit Against Ionis Over Plozasiran FCS Treatment
去年
Plozasiran Shows Promise in Reducing Triglycerides in Familial Chylomicronemia Syndrome and Severe Hypertriglyceridemia
去年
Sanofi Acquires Rights to Plozasiran for $395 Million in Greater China Deal with Arrowhead
3天前
FDA Approves Bexlutry, First Generic Radioligand Therapy, After Curium Wins Novartis Patent Dispute
去年
Arrowhead Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome
第 1 页,共 85 页
上一页
下一页